Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
Haoqiang Ying(Dana-Farber Cancer Institute), Alec C. Kimmelman(Dana-Farber Cancer Institute), Costas A. Lyssiotis(Beth Israel Deaconess Medical Center), Sujun Hua(Dana-Farber Cancer Institute), Gerald C. Chu(Brigham and Women's Hospital), Eliot Fletcher-Sananikone(Dana-Farber Cancer Institute), Jason W. Locasale(Beth Israel Deaconess Medical Center), Jaekyoung Son(Dana-Farber Cancer Institute), Hailei Zhang(Dana-Farber Cancer Institute), Jonathan L. Coloff(Harvard University), Haiyan Yan(Dana-Farber Cancer Institute), Wei Wang(Brigham and Women's Hospital), Shujuan Chen(Dana-Farber Cancer Institute), Andrea Viale(Dana-Farber Cancer Institute), Hongwu Zheng(Dana-Farber Cancer Institute), Ji-Hye Paik(Dana-Farber Cancer Institute), Carol S. Lim(Dana-Farber Cancer Institute), Alexander R. Guimarães(Massachusetts General Hospital), Eric S. Martin(Dana-Farber Cancer Institute), Jeffery Chang(Dana-Farber Cancer Institute), Aram F. Hezel(Dana-Farber Cancer Institute), Samuel R. Perry(Dana-Farber Cancer Institute), Jian Hu(Dana-Farber Cancer Institute), Boyi Gan(Dana-Farber Cancer Institute), Yonghong Xiao(Dana-Farber Cancer Institute), John M. Asara(Beth Israel Deaconess Medical Center), Ralph Weissleder(Harvard University), Yanru Wang(Dana-Farber Cancer Institute), Lynda Chin(Brigham and Women's Hospital), Lewis C. Cantley(Beth Israel Deaconess Medical Center), Ronald A. DePinho(The University of Texas MD Anderson Cancer Center)
Cited by 2,035Open Access
Abstract
Related Papers
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Frank Weinberg, Robert B. Hamanaka, William W. Wheaton et al.|Proceedings of the National Academy of Sciences|2010|1.7k